ISCOM technology-based Matrix M (TM) adjuvant: success in future vaccines relies on formulation

KL Bengtsson, B Morein, Ab Osterhaus

Research output: Contribution to journalArticleAcademicpeer-review

100 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)401-403
Number of pages3
JournalExpert Review of Vaccines
Volume10
Issue number4
DOIs
Publication statusPublished - 2011

Cite this